| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 24 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 24 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 24 |
| 3 | ETOPOSIDE | 17 |
| 4 | IFOSFAMIDE | 15 |
| 5 | IFOSFAMIDE FOR INJECTION | 15 |
| 6 | DOXORUBICIN | 14 |
| 7 | CARBOPLATIN | 11 |
| 8 | LAMIVUDINE | 11 |
| 9 | LAMIVUDINE ORAL | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 9 | 0.0041 |
| 1 | FAMOTIDINE 20MG | 1 | 0.0027 |
| 2 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 3 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 4 | PEGFILGRASTIM-CBQV | 2 | 0.0014 |
| 5 | ZIDOVUDINE | 11 | 0.0011 |
| 6 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 7 | IFOSFAMIDE FOR INJECTION | 15 | 0.0007 |
| 8 | SAXAGLIPTIN | 1 | 0.0007 |
| 9 | TOPOTECAN | 4 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 9 | 0.0041 |
| 1 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 3 | Topoisomerase Inhibitor [EPC] | 20 | 0.0003 |
| 4 | Cannabinoid [EPC] | 2 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |
| 7 | Antisense Oligonucleotide [EPC] | 2 | 0.0002 |
| 8 | Alkylating Drug [EPC] | 38 | 0.0002 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |